*By The Canadian Press*
KENILWORTH, N.J. — Merck & Co. will stop its study of an experimental Alzheimer's drug in people with mild or moderate symptoms because interim results showed "virtually no chance" of any benefit.
However, the drugmaker said Tuesday it will continue another study of the drug, verubecestat, in...
Merck Alzheimer's drug fails in 1 study; another continues
Tuesday, 14 February 2017
Wochit News - ▶ 00:35